Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis ; volume:10 ; number:3 ; day:28 ; month:11 ; year:2012 ; pages:1 ; date:11.2012
Journal of translational medicine ; 10, Heft 3 (28.11.2012), 1, 11.2012
- Creator
-
Ćalasan, Maja Bulatović
- Contributor
-
Vastert, Sebastiaan
Verweij, Frederik
Wulffraat, Nico
van Wijk, Femke
Prakken, Berent
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-S3-P40
- URN
-
urn:nbn:de:1111-2016041443796
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ćalasan, Maja Bulatović
- Vastert, Sebastiaan
- Verweij, Frederik
- Wulffraat, Nico
- van Wijk, Femke
- Prakken, Berent
- SpringerLink (Online service)
Other Objects (12)
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance